A retrospective study has been conducted on patients with onychomycosis, a fungal infection of the nails, who were treated with ciclopirox 8% HPCH and oral antifungals. The study utilized artificial intelligence to analyze electronic health records, but its specific findings are not clear. Other research has also been focused on various aspects of onychomycosis, including non-dermatophyte pathogens and severe complications in immunocompetent patients.